Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 4, 2012, Pages 344-354

  Petri, Aspasia ^a   Yova, Dido ^a   Alexandratou, Eleni ^a   Kyriazi, Maria ^a   Rallis, Michail ^b  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Foscan; Fospeg; Photodynamic therapy; Prostate cancer cells

Indexed keywords

DRUG CARRIER; FOSPEG; LIPOSOME; PHOTOSENSITIZING AGENT; TEMOPORFIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CANCER;

CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; LIPOSOMES; MALE; MESOPORPHYRINS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS;

EID: 84870372048     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2012.03.008     Document Type: Article

References (30)

1. Mitra S., Foster T.H. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs photofrin. Photochem Photobiol 2005, 81(4):849-859.
2. Chen Y., Zhang L.L.M., Shen T. An explanation to the high efficiency of m-THPC (Temporfin) used in photodynamic therapy. Chin Sci Bull 2001, 46(10):823-827.
3. Dragicevic-Curic N., Gräfe S., Gitter B., Fahr A. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines. J Photochem Photobiol B: Biol 2010, 101(3):238-250.
4. Molinari A., Colone M., Calcabrini A., et al. Cationic liposomes, loaded with m-THPC, in photodynamic therapy for malignant glioma. Toxicol In Vitro 2007, 21(2):230-234.
5. Marchal S., François A., Dumas D., Guillemin F., Bezdetnaya Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells. Br J Cancer 2007, 96:944-951.
6. Pegaza B., Debefve E., Ballini J.P., et al. Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci 2006, 28(1-2):134-140.
7. Hofman J.W., Carstens M.G., van Zeeland F., et al. Photocytotoxicity of mTHPC (Temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation. Pharm Res 2008, 25(9):2065-2073.
8. Kachatkou D., Sasnouski S., Zorin V., et al. Unusual photoinduced response of mTHPC liposomal formulation (Foslip). Photochem Photobiol 2009, 85(3):719-724.
9. Mojzisova H., Bonneau S., Brault D. Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells. Eur Biophys J 2007, 36(8):943-953.
10. Wojtyk J.T.C., Goyan R., Gudgin-Dickson E., Pottier R. Exploiting tumour biology to develop novel drug delivery strategies for PDT. Med Laser Appl 2006, 21:225-238.
11. Paszko E., Ehrhardt C., Senge M.O., Kelleher D.P., Reynolds J.V. Nanodrug applications in photodynamic therapy. Photodiagn Photodyn Ther 2011, 8(1):14-29.
12. Gyenge E.B., Hiestand S., Graefe S., Walt H., Maake C. Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro. Photodiagn Photodyn Ther 2011, 8(2):86-96.
13. Derycke A.S., de Witte P.A. Liposomes for photodynamic therapy. Adv Drug Deliv Rev 2004, 56(1):17-30.
14. de Visscher S.A., KaŠčáková S., de Bruijn H.S., et al. Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model. Lasers Surg Med 2011, 43(6):528-536.
15. Kuntsche J., Freisleben I., Steiniger F., Fahr A. Temoporfin-loaded liposomes: physicochemical characterization. Eur J Pharm Sci 2010, 40(4):305-315.
16. Nawalany K., Rusin A., Kepczynski M., et al. Comparison of photodynamic efficacy of tetraarylporphyrin pegylated or encapsulated in liposomes: in vitro studies. J Photochem Photobiol B: Biol 2009, 97:8-17.
17. Moore C.M., Emberton M., Bown S.G. Photodynamic therapy for prostate cancer-an emerging approach for organ-confined disease. Lasers Surg Med 2011, 43:768-775.
18. Evans A.J., Ryan P., Van derKwast T. Treatment effects in the prostate including those associated with traditional and emerging therapies. Adv Anat Pathol 2011, 18:281-293.
19. Reuther T., Kuebler A.C., Zillmann U., Flechtenmacher C., Sinn H. Comparison of the in vivo effciency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-Mediated PDT in a human xenografted head and neck carcinoma. Lasers Surg Med 2001, 29(4). 314±322.
20. Teiten M.H., Bezdetnaya L., Merlin J.L., et al. Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells. J Photochem Photobiol B: Biol 2001, 62(3):146-152.
21. Berland J., Kiesslich T., Engelhardt V., Krammer B., Plaetzer K. Comparative in vitro study on the characteristics of different photosensitizers employed in PDT. J Photochem Photobiol B: Biol 2010, 100(3):173-180.
22. Belitchenko I., Melnikova V., Bezdetnaya L., et al. Characterization of photodegradation of meta-tetra (Hydroxyphenyl) chlorin (mTHPC) in solution: biological consequences in human tumor cells. Photochem Photobiol 1998, 67(5):584-590.
23. Kascakova S., Kruijt B., de Bruijn H.S., et al. Ex vivo quantification of mTHPC concentration in tissue: influence of chemical extraction on the optical properties. J Photochem Photobiol B: Biol 2008, 91(2-3):99-107.
24. Yow C.M.N., Mak N.K., Leung A.W.N., Huang Z. Induction of early apoptosis in human nasopharyngeal carcinoma cells by mTHPC-mediated photocytotoxicity. Photodiagn Photodyn Ther 2009, 6(2):122-127.
25. Sasnouski S., Zorin V., Khludeyev I., D'Hallewin M.A., Guillemina F., Bezdetnaya L. Investigation of Foscan interactions with plasma proteins. Biochim Biophys Acta 2005, 1725(3):394-402.
26. Chen K., Wacker M., Hackbarth S., Ludwig C., Langer K., Röder B. Photophysical evaluation of mTHPC-loaded HSA nanoparticles as novel PDT delivery systems. J Photochem Photobiol B: Biol 2010, 101(3):340-347.
27. Lassalle H., Wagner M., Bezdetnaya L., Guillemin F., Schneckenburger H. Fluorescence imaging of Foscan and Foslip in the plasma membrane and in whole cells. J Photochem Photobiol B: Biol 2008, 92(1):47-53.
28. Melnikova V.O., Bezdetnaya L.N., Bour C., et al. Subcellular localization of meta-tetra(hydroxyphenyl) chlorin in human tumor cells subjected to photodynamic treatment. J Photochem Photobiol B: Biol 1999, 49(2-3):96-103.
29. Teiten M.H., Bezdetnaya L., Morliere P., Santus R., Guillemin F. Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localization in cultured tumour cells. Br J Cancer 2003, 88(1):146-152.
30. Huang Y.Y., Chen A.C.H., Carroll J.D., Hamblin M.R. Biphasic dose response in low level light therapy. Dose Response 2009, 7(4):358-383.